SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Shares, par value US$0.001 per share
- Shares outstanding
- 71,872,133
- Total 13F shares
- 13,494,548
- Share change
- -163,813
- Total reported value
- $79,577,415
- Price per share
- $6.47
- Number of holders
- 10
- Value change
- -$1,059,870
- Number of buys
- 1
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP P8696W104:
Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.8%
|
2,718,735
|
$340,000,000 | — | 31 Mar 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
16%
|
11,800,000
|
$76,346,000 | — | 31 Mar 2024 | |
| Neumann Advisory Hong Kong Ltd |
13F
|
Company |
0.44%
|
315,586
|
$2,042,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
160,875
|
$1,040,861 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.8%
|
1,312,520
|
$849,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,717
|
$179,328 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
16,430
|
$106,302 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
12,750
|
$82,492 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
6,924
|
$44,798 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3,000
|
$19,410 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,095
|
$13,555 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
412
|
$2,666 | — | 31 Mar 2024 | |
| Transamerica Financial Advisors, LLC |
13F
|
Company |
0%
|
2
|
$1,000 | — | 31 Mar 2024 | |
| Horizon Investments, LLC |
13F
|
Company |
0%
|
52
|
$336 | — | 31 Mar 2024 |
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q2 2024
As of 30 Jun 2024,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,494,548 shares.
The largest 10 holders included
Vivo Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Neumann Advisory Hong Kong Ltd, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, UBS Group AG, GROUP ONE TRADING, L.P., and Horizon Investments, LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
11
Q2 2024 holders
10
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.